Harvest Group Wealth Management’s BioNTech BNTX Stock Holding History

Harvest Group Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2	Closed	–	–	169
2022 Q2	$0	Buy	+2	New	+$306	﹤0.01%	183

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Harvest Group Wealth Management's BNTX Position: Q3 2022 in Review

Harvest Group Wealth Management sold out of BioNTech (BNTX) in Q3 2022, closing a stake of 2 shares.

Harvest Group Wealth Management first reported a position in BNTX in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

Harvest Group Wealth Management reported no remaining BioNTech position as of Q3 2022 after selling out during the quarter.
Harvest Group Wealth Management sold 2 BioNTech shares in Q3 2022.
Harvest Group Wealth Management first reported a position in BioNTech in Q2 2022 and held it in 1 quarter.
Harvest Group Wealth Management's BioNTech position peaked at $0 in Q2 2022.
264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on Harvest Group Wealth Management's 13F filing for Q3 2022, filed 8 Nov 2022.